On an yearly basis, gross profit for FY24 was Rs16,291 million, up 22 per cent from Rs 13,328 million in FY23
Read More
In Q4 FY24, JB Pharma recorded a revenue of Rs 862 crores, marking a 13 per cent increase from Rs 762 crores in Q4 FY23
Read More
In Q4 FY24, Mankind Pharma reported revenue from operations of Rs 2,441 Cr, marking a notable 19 per cent year-on-year (YoY) increase
Read More
"The Indian pharmaceutical market for chronic diseases is experiencing significant growth. By leveraging our expertise in chronic therapies and dedication to innovation and brand development, JB Pharma is well-positioned to continue its upward trajectory in the Indian pharmaceutical market." - Dilip Singh Rathore, President-India Business, JB Pharma
Read More
Technology, skills and learnings are industry-agnostic. It's your mindset that enables the implementation of a basic idea from one industry into something revolutionary in another says Priyanka
Read More
Established in 2011 as a 50:50 joint venture for pharmaceutical sales and marketing in India, Bayer has now acquired the remaining 25 per cent stake to secure full ownership of the entity, in accordance with pre-agreed joint venture terms
Read More
The ‘Cure and Beyond’ campaign not only aims to spotlight innovation as the cornerstone of Emcure's operations but also endeavors to instill a sense of thought leadership within the Indian pharmaceutical sector
Read More
